SSGJ-705 Monotherapy and Combination Therapy in Advanced HER2-Expressing Solid Tumors

Clinical trial NCT07022002 · RECRUITING

Trial details

NCT number: NCT07022002
Sponsor: Shenyang Sunshine Pharmaceutical Co., LTD.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Locally Advanced, Recurrent or Metastatic Malignancies

Start date: 2025-07-30
Primary completion: 2026-12-31
Enrollment: 340

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.